BPA Call 36C24924A0032-36C24926N0423
Award Date 4/1/26
Potential Completion Date 3/31/29
Potential Value $471K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
Not listed Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Des Plaines, IL 60018, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, received a BPA call award valued at $421,177.66 for Alinity reagents, controls, and consumables to support Veterans Integrated Service Network 6 (VISN 6). The contract is issued under the In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule and represents a firm fixed-price delivery order under a larger blanket purchase agreement with an $3.8 million ceiling extending through April 2029. The award does not carry a small...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a Blanket Purchase Agreement (BPA) call valued at $2.7 million by Veterans Integrated Service Network 19 on December 1, 2022, with an ultimate completion date of November 30, 2023. This firm fixed-price contract, issued under the General Services Administration's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule, covers Alinity M reagents and supplies to be delivered to the VA facility in Aurora, Colorado. Abbott...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, received a Blanket Purchase Agreement (BPA) call order valued at $2.76 million from Veterans Integrated Service Network 19 for Alinity M reagents and supplies. The contract, awarded on December 1, 2023, with completion targeted for November 30, 2024, operates under the General Services Administration's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule and utilizes firm fixed pricing. The supplies will be delivered to the...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a $550,000 Blanket Purchase Agreement (BPA) call for Alinity M reagents and supplies by Veterans Integrated Service Network (VISN) 19, effective through November 30, 2025. The contract utilizes firm fixed pricing and is issued under the parent GSA Schedule vehicle for In-Vitro Diagnostics, Reagents, and Test (FSS-65-VII). Performance will be conducted at Abbott Molecular's facility in Aurora, Colorado. This award...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories and leading supplier of molecular diagnostic products, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call for Alinity M reagents valued at $996,003.70. The contract, awarded on October 1, 2025, supports the Department of Veterans Affairs Veterans Integrated Service Network 2 and is scheduled for completion by September 30, 2026. The work will be performed in Des Plaines, Illinois. This award represents a task order...
- This federal contract award was issued by the Veterans Integrated Service Network 9 (VISN 9), a component of the U.S. Department of Veterans Affairs (VA), to Abbott Molecular Inc. The $143,680.23 Blanket Purchase Agreement (BPA) call order is for the supply of i-STAT diagnostics equipment, reagents, and related services during Fiscal Year 2016. The BPA falls under the GSA schedule contract for Critical Analyzers, Laboratory (FSS-66-III) and has a firm fixed-price structure. No set-aside...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a Blanket Purchase Agreement (BPA) call valued at $238,624.26 by Veterans Integrated Service Network 20 (VISN 20) on August 1, 2024, for accessories, reagent kits, consumables, supplies, and maintenance services supporting SARS-CoV-2, hepatitis C virus (HCV), HIV, and hepatitis B virus (HBV) polymerase chain reaction (PCR) testing. The award is a firm fixed-price contract issued under the parent GSA Schedule for In-Vitro...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a $1.31M firm fixed-price Blanket Purchase Agreement (BPA) call for Alinity M reagents and supplies by Veterans Integrated Service Network 19 on December 1, 2021, with completion scheduled for November 30, 2022. The contract, issued under the General Services Administration's In-Vitro Diagnostics, Reagents, Test schedule (FSS-65-VII), supports molecular diagnostic testing operations at the VA facility in Aurora, Colorado....
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a Blanket Purchase Agreement call valued at $2.7 million on January 11, 2022, for COVID-19 reagents supporting the Alinity M molecular diagnostic analyzer platform. The contract, funded by Veterans Integrated Service Network 19 (a civilian entity within the Department of Veterans Affairs), was performed at Abbott Molecular's Aurora, Colorado facility with a completion date of November 30, 2022. As a firm fixed-price delivery...
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, received an administrative correction call order valued at $373,277.97 under a Blanket Purchase Agreement with Veterans Integrated Service Network 15, a division of the Department of Veterans Affairs. This firm fixed-price delivery order, awarded on October 15, 2024, with a completion date of October 14, 2025, adds products to the contract's attachment and procures COVID-19 testing molecular analyzers and reagents designed for...